BP
VAR

Ballentine Partners’s Varian Medical Systems, Inc. VAR Stock Holding History

Ballentine Partners’s Portfolio VAR Stock Details VAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,172
Closed -$201K – 416
2020
Q3 		$201K Buy
+1,172
New +$184K 0.01% 361
2020
Q2 		– Sell
-2,264
Closed -$232K – 394
2020
Q1 		$232K Buy
2,264
+852
+60% +$113K 0.01% 294
2019
Q4 		$201K Buy
+1,412
New +$180K 0.01% 388

Other funds holding VAR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PSquared Asset Management Zurich, Switzerland $287M AUM 58.62% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Ballentine Partners's VAR Position: Q4 2020 in Review

Ballentine Partners sold out of Varian Medical Systems, Inc. (VAR) in Q4 2020, closing a stake of 1,172 shares — an estimated $201K sold.

Ballentine Partners first reported a position in VAR in Q4 2019 and held it in 3 quarters. The position peaked at $232K in Q1 2020. 636 funds tracked by Wall St. Rank hold VAR as of Q4 2020.

  • Ballentine Partners reported no remaining Varian Medical Systems, Inc. position as of Q4 2020 after selling out during the quarter.
  • Ballentine Partners sold 1,172 Varian Medical Systems, Inc. shares in Q4 2020, an estimated $201K.
  • Ballentine Partners first reported a position in Varian Medical Systems, Inc. in Q4 2019 and held it in 3 quarters.
  • Ballentine Partners's Varian Medical Systems, Inc. position peaked at $232K in Q1 2020.
  • 636 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q4 2020.

Based on Ballentine Partners's 13F filing for Q4 2020, filed 25 Jan 2021.